SEC 13F Intelligence

Managers / Q1 2019 · view latest →

C WorldWide Group Holding A/S

CIK 0001625244 · DAMPFAERGEVEJ 26, COPENHAGEN, G7, 2100 · 004535463500

Reported Value
$7.9B
Q1 2019
Positions
152
Filings on Record
29
2019–present window
Filed
May 3, 2019
original filing

Summary

C Worldwide Group Holding A/S reported $7.9B in U.S.-listed holdings across 152 positions for Q1 2019.

Its largest position, V, represents 15.1% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+72.7%
share of reported value
Largest Position
+15.1%
Visa

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $7.9BQ1 ’19Q2 ’19: $8.0BQ3 ’19: $7.9BQ4 ’19: $8.4BQ1 ’20: $7.2BQ1 ’20Q2 ’20: $8.6BQ3 ’20: $8.9BQ4 ’20: $10.0BQ1 ’21: $10.2BQ1 ’21Q2 ’21: $9.7BQ3 ’21: $9.7BQ4 ’21: $10.6BQ1 ’22: $9.2BQ1 ’22Q2 ’22: $8.0BQ3 ’22: $7.3BQ4 ’22: $7.5BQ1 ’23: $7.3BQ1 ’23Q2 ’23: $7.7BQ3 ’23: $7.3BQ4 ’23: $7.5BQ1 ’24: $8.8BQ1 ’24Q2 ’24: $9.2BQ3 ’24: $9.6BQ4 ’24: $8.2BQ1 ’25: $8.1BQ1 ’25Q2 ’25: $7.4BQ3 ’25: $6.5BQ4 ’25: $5.7BQ1 ’26: $4.7BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 87.4%ADR: 6.0%REIT: 5.7%Other: 0.8%
  • Common Stock · 87.4% · $6.9B
  • ADR · 6.0% · $474M
  • REIT · 5.7% · $449M
  • Other · 0.8% · $66M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
VVISA INCNEW+7.60M7.60M+$1.2B$1.2B
TMOTHERMO FISHER SCIENTIFIC INCNEW+2.22M2.22M+$608M$608M
ECLECOLAB INCNEW+3.37M3.37M+$595M$595M
HDHOME DEPOT INCNEW+3.00M3.00M+$576M$576M
GOOGALPHABET INCNEW+479.6K479.6K+$563M$563M
AMZNAMAZON INCNEW+303.5K303.5K+$540M$540M
MSFTMICROSOFT CORPNEW+4.07M4.07M+$479M$479M
AMTAMERICAN TOWER CORP NEWNEW+2.11M2.11M+$415M$415M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

112 positions (from 152 filing rows — )
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1VVISA INChistory →COM CL A15.07%$1.2B7.60M
2TMOTHERMO FISHER SCIENTIFIC INChistory →COM7.71%$608M2.22M
3ECLECOLAB INChistory →COM7.54%$595M3.37M
4HDHOME DEPOT INChistory →COM7.31%$576M3.00M
5GOOGALPHABET INCCAP STK CL C · CAP STK CL A7.15%$564M480.5K
6AMZNAMAZON INChistory →COM6.86%$540M303.5K
7MSFTMICROSOFT CORPhistory →COM6.08%$479M4.07M
8AMTAMERICAN TOWER CORP NEWhistory →COM5.26%$415M2.11M
9PGPROCTER AND GAMBLE COhistory →COM4.95%$390M3.75M
10KOCOCA COLA COhistory →COM4.74%$374M7.98M
11EXMOCEXXON MOBIL CORPhistory →COM4.33%$341M4.22M
12FRCBFIRST REP BK SAN FRANCISCO Chistory →COM3.98%$313M3.12M
13WFCWELLS FARGO CO NEWhistory →COM3.59%$283M5.85M
14HDBHDFC BANK LTDhistory →SPONSORED ADS2.48%$195M1.68M
15BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS2.03%$160M875.8K
16IBNICICI BK LTDhistory →ADR0.78%$61M5.36M
17SBUXSTARBUCKS CORPhistory →COM0.70%$56M746.9K
18JNJJOHNSON & JOHNSONhistory →COM0.59%$47M334.1K
19BIDUBAIDU INChistory →SPON ADR REP A0.52%$41M247.6K
20UNHUNITEDHEALTH GROUP INChistory →COM0.46%$36M145.6K
21USBUS BANCORP DELhistory →COM NEW0.44%$35M724.9K
22PFEPFIZER INChistory →COM0.42%$33M784.2K
23MDLZMONDELEZ INTL INChistory →CL A0.41%$33M652.0K
24CVSCVS HEALTH CORPhistory →COM0.37%$29M535.6K
25WYWEYERHAEUSER COhistory →COM0.36%$28M1.08M
26MRKMERCK & CO INChistory →COM0.35%$27M330.0K
27BIOHAVEN PHARMACTL HLDG CO LCOM0.25%$20M381.8K
28AMARIN CORP PLCSPONS ADR NEW0.20%$16M761.3K
29AMGNAMGEN INChistory →COM0.19%$15M80.8K
30HCAHCA HEALTHCARE INChistory →COM0.19%$15M112.9K
31BSXBOSTON SCIENTIFIC CORPhistory →COM0.18%$14M367.2K
32BDXBECTON DICKINSON & COhistory →COM0.17%$13M53.0K
33GILDGILEAD SCIENCES INChistory →COM0.16%$13M196.6K
34VRTXVERTEX PHARMACEUTICALS INChistory →COM0.16%$13M68.6K
35LLYLILLY ELI & COhistory →COM0.15%$12M91.8K
36ALLERGAN PLCSHS0.14%$11M75.9K
37ABBVABBVIE INChistory →COM0.13%$10M125.8K
38CNCCENTENE CORP DELCOM0.13%$10M187.3K
39BIIBBIOGEN INCCOM0.12%$10M41.6K
40HOLOGIC INCCOM0.12%$10M199.3K
41CELGCELGENE CORPCOM0.12%$9M98.0K
42EWEDWARDS LIFESCIENCES CORPCOM0.11%$9M45.9K
43LIVNLIVANOVA PLCSHS0.10%$8M83.2K
44ISRGINTUITIVE SURGICAL INCCOM NEW0.10%$7M13.1K
45TAKTAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS0.09%$7M366.4K
46MYLAN N VSHS EURO0.09%$7M257.5K
47AERIE PHARMACEUTICALS INCCOM0.08%$6M136.1K
48ALXNALEXION PHARMACEUTICALS INCCOM0.08%$6M47.3K
49HRTXHERON THERAPEUTICS INCCOM0.08%$6M252.1K
50BMRNBIOMARIN PHARMACEUTICAL INCCOM0.08%$6M68.9K
51TDOCTELADOC HEALTH INCCOM0.07%$6M104.8K
52PORTOLA PHARMACEUTICALS INCCOM0.07%$6M159.4K
53TSMTAIWAN SEMICONDUCTOR MFG LTDSPONSORED ADS0.07%$5M134.1K
54NVCRNOVOCURE LTDORD SHS0.07%$5M108.1K
55EXKEXACT SCIENCES CORPCOM0.06%$5M58.9K
56HORIZON PHARMA PLCSHS0.06%$5M191.5K
57LHC GROUP INCCOM0.06%$5M45.7K
58PODDINSULET CORPCOM0.06%$5M52.7K
59VOCERA MUNICATIONS INCCOM0.06%$5M155.1K
60CICIGNA CORP NEWCOM0.06%$5M30.0K
61THERAPEUTICSMD INCCOM0.06%$5M989.8K
62STEMLINE THERAPEUTICS INCCOM0.06%$5M358.1K
63ILMNILLUMINA INCCOM0.06%$5M14.5K
64DERMIRA INCCOM0.06%$4M324.9K
65SPARK THERAPEUTICS INCCOM0.05%$4M37.4K
66JAZZJAZZ PHARMACEUTICALS PLCSHS USD0.05%$4M29.8K
67AIMTAIMMUNE THERAPEUTICS INCCOM0.05%$4M182.7K
68INTERSECT ENT INCCOM0.05%$4M123.5K
69GW PHARMACEUTICALS PLCADS0.05%$4M23.5K
70DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW0.05%$4M496.4K
71COLLCOLLEGIUM PHARMACEUTICAL INCCOM0.05%$4M236.0K
72GKOSGLAUKOS CORPCOM0.04%$3M44.3K
73INCYINCYTE CORPCOM0.04%$3M38.7K
74INSMINSMED INCCOM PAR $.010.04%$3M113.1K
75DXCMDEX INCCOM0.04%$3M26.9K
76NEONEOGENOMICS INCCOM NEW0.04%$3M149.4K
77SRPTSAREPTA THERAPEUTICS INCCOM0.04%$3M25.3K
78CERNER CORPCOM0.04%$3M50.3K
79CARA THERAPEUTICS INCCOM0.04%$3M143.5K
80CHRSCOHERUS BIOSCIENCES INCCOM0.03%$3M198.5K
81RAREULTRAGENYX PHARMACEUTICAL INCOM0.03%$3M38.2K
82CCICROWN CASTLE INTL CORP NEWCOM0.03%$3M19.9K
83AQNALGONQUIN PWR UTILS CORPCOM0.03%$3M167.9K
84PARATEK PHARMACEUTICALS INCCOM0.03%$3M470.1K
85TAT&T INCCOM0.03%$2M77.2K
86ACCELERATE DIAGNOSTICS INCCOM0.03%$2M114.7K
87PGRPROGRESSIVE CORP OHIOCOM0.03%$2M32.4K
88ELVANTHEM INCCOM0.03%$2M8.1K
89VKTXVIKING THERAPEUTICS INCCOM0.03%$2M232.1K
90ATLANTICA YIELD PLCSHS0.03%$2M116.6K
91TDTORONTO DOMINION BK ONTCOM NEW0.03%$2M31.2K
92PFENEX INCCOM0.03%$2M352.2K
93IOVAIOVANCE BIOTHERAPEUTICS INCCOM0.03%$2M226.7K
94FNVFRANCO NEVADA CORPCOM0.02%$2M25.8K
95ARMKARAMARKCOM0.02%$2M65.0K
96STORE CAP CORPCOM0.02%$2M56.8K
97INTRA CELLULAR THERAPIES INCCOM0.02%$2M146.7K
98FOAMIX PHARMACEUTICALS LTDSHS0.02%$2M442.9K
99OTEXOPEN TEXT CORPCOM0.02%$2M31.5K
100CLOVIS ONCOLOGY INCCOM0.02%$2M63.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$4.7B97May 6, 202613F-HRchanges · EDGAR ↗
Q4 2025$5.7B97Feb 4, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.5B95Nov 5, 202513F-HRchanges · EDGAR ↗
Q2 2025$7.4B93Aug 6, 202513F-HRchanges · EDGAR ↗
Q1 2025$8.1B92May 5, 202513F-HRchanges · EDGAR ↗
Q4 2024$8.2B91Feb 4, 202513F-HRchanges · EDGAR ↗
Q3 2024$9.6B91Nov 5, 202413F-HRchanges · EDGAR ↗
Q2 2024$9.2B89Jul 31, 202413F-HRchanges · EDGAR ↗
Q1 2024$8.8B85May 3, 202413F-HRchanges · EDGAR ↗
Q4 2023$7.5B84Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$7.3B85Nov 3, 202313F-HRchanges · EDGAR ↗
Q2 2023$7.7B84Aug 2, 202313F-HRchanges · EDGAR ↗
Q1 2023$7.3B85May 2, 202313F-HRchanges · EDGAR ↗
Q4 2022$7.5B122Feb 3, 202313F-HRchanges · EDGAR ↗
Q3 2022$7.3B126Nov 3, 202213F-HRchanges · EDGAR ↗
Q2 2022$8.0B133Aug 2, 202213F-HRchanges · EDGAR ↗
Q1 2022$9.2B121May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$10.6B135Feb 2, 202213F-HRchanges · EDGAR ↗
Q3 2021$9.7B129Nov 1, 202113F-HRchanges · EDGAR ↗
Q2 2021$9.7B123Aug 4, 202113F-HRchanges · EDGAR ↗
Q1 2021$10.2B133May 4, 202113F-HRchanges · EDGAR ↗
Q4 2020$10.0B133Feb 5, 202113F-HRchanges · EDGAR ↗
Q3 2020$8.9B133Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$8.6B125Aug 5, 202013F-HRchanges · EDGAR ↗
Q1 2020$7.2B130May 4, 202013F-HRchanges · EDGAR ↗
Q4 2019$8.4B123Feb 5, 202013F-HRchanges · EDGAR ↗
Q3 2019$7.9B116Nov 4, 201913F-HRchanges · EDGAR ↗
Q2 2019$8.0B125Aug 2, 201913F-HRchanges · EDGAR ↗
Q1 2019$7.9B152May 3, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • C WorldWide Fund Management A/S028-16307
  • C WorldWide Asset Management Fondsmaeglerselskab A/S028-16306

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.